Author
Sean Carmichael
Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.
Enterprise Software: Assessing AI Adoption Trends
Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Most-Favored-Nation Policy: Implications for European Drug Launches
The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
Navigating Biopharma Policy
Biopharma firms are grappling with a turbulent and complex policy landscape.
Is FDA's Real-Time CRL Disclosure a Boon or Bane?
With the help of Tegus Expert Insights and other tools available in AlphaSense, let’s dive into the FDA’s CRL decision and the market implications.
Biotech M&A: Trends and 2026 Outlook
Now, a surge in M&A is reversing the trend as Big Pharma turns to acquisitions to offset patent losses and fuel innovation.
Biotech M&A: Trends and 2026 Outlook
We use the AlphaSense platform to explore M&A trends in biotech, key drivers, and market implications.
Navan and the Travel Management Market | An AlphaSense Primer
Using the AlphaSense platform, we dive into Navan, its growth prospects, and the competitive dynamics of the travel management market.
Fermi and the Data Center REIT Market | An AlphaSense Primer
Get your primer on Fermi’s IPO and the competitive forces shaping the data center REIT market.
NVIDIA and the Structural Investments Fueling the AI Buildout
As AI investment has shifted from experimental to structural, it has created unprecedented visibility into AI demand trends.
Netskope and the Cybersecurity Market | An AlphaSense Primer
Get your primer on Netskope’s IPO and the competitive forces shaping the cybersecurity market.
AI in Drug Discovery & Development
Hype, Reality, and What Comes Next
McGraw Hill and the Educational Publishing Market | An AlphaSense Primer
Get your primer on McGraw Hill’s IPO and the competitive forces shaping the educational publishing market.
StubHub and the Global Ticketing Market | An AlphaSense Primer
Harnessing insights from the AlphaSense platform, we analyze StubHub, its strategic priorities, and how it stacks up against competitors in the global ticketing market.
Klarna and the Buy Now, Pay Later Market | An AlphaSense Primer
Using the AlphaSense platform, we dive into Klarna, its growth prospects, and the competitive dynamics of the buy now pay later (BNPL) market.
CATL and the EV Battery Market | An AlphaSense Primer
Get your primer on CATL’s Hong Kong IPO and the competitive forces shaping the EV battery market.
Hinge Health and the Digital Health Market | An AlphaSense Primer
Monitor competitors, track market trends, and stay ahead with AlphaSense dashboards. Turn information overload into actionable insights fast.
Figma and the Creative Cloud Market | An AlphaSense Primer
We leverage insights from AlphaSense’s Expert Transcript Library to learn about Figma and assess the competitive dynamics of the creative cloud space.
Circle and the Stablecoin Market | An AlphaSense Primer
Get your primer on Circle’s IPO and the competitive forces shaping the stablecoin market.
Chime Financial and the Neobanking Market | An AlphaSense Primer
Get your primer on Chime’s IPO and the competitive forces shaping the neobanking market.
Long-Term Outlook for Data Center Equipment Growth
Long-Term Outlook for Data Center Equipment Growth
Leveraging Expert Transcripts for Private Company Research
Discover how AlphaSense’s expert calls can provide a competitive advantage in the private equity investment space.
Transform intelligence
into advantage
Develop bold strategies, seize opportunities, and lead with clarity and confidence.